Skip to main content
Premium Trial:

Request an Annual Quote

Thrive Earlier Detection: Sam Asgarian, Frank Diehl, Dina Ciarimboli

Thrive Earlier Detection has appointed Sam Asgarian is its new chief medical officer, Frank Diehl as executive vice president of product solutions, and Dina Ciarimboli as chief legal officer.

Asgarian will lead the firm's medical strategy, including the integration of its CancerSEEK early detection test into routine medical care. He was most recently vice president of CVS Health's Transformation Health Product organization. Asgarian joined CVS as part of the Aetna acquisition, having served as the chief medical officer of Aetna's clinical services organization, overseeing medical management and clinical policy operations. He holds a BA in molecular and cell biology from the University of California at Berkeley, an MA in medical sciences from Loyola University Chicago, an MD from Tulane University, and an MBA from Cornell University.

Diehl is a globally recognized leader in cancer biology and detection who has pioneered the use of circulating tumor DNA to detect and track the progression of cancer. In 2008, he cofounded liquid biopsy firm Inostics, where he served as chief scientific officer through its acquisition by Sysmex, ultimately becoming CEO of Sysmex Inostics. Diehl completed his postdoc at the Ludwig Center for Cancer Genetics and Therapeutics at Johns Hopkins University and worked in the laboratory of Thrive cofounders Bert Vogelstein and Kenneth Kinzler. He holds a PhD in molecular pathology from Ruprecht-Karls University in Heidelberg, Germany.

Ciarimboli's appointment follows her interim role as general counsel. Prior to joining Thrive full time, she was general counsel at Third Rock Ventures. Before that, she served as general counsel to several venture capital firms focused on early-stage investing in various industries including biotech, diagnostics, medical devices, and healthcare services. Earlier, she served as an associate at Testa, Hurwitz & Thibeault, and as a senior associate at PricewaterhouseCoopers. Ciarimboli holds a BA in accounting and philosophy from Boston College and a JD from Boston College School of Law.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.